MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Owlstone Medical Ltd
Organization & Developments: Owlstone Medical
Parents
Owlstone Medical Ltd
Children
*Owlstone Medical is developing a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease.
*The global leader in Breath Biopsy for early detection and precision medicine
2024: Gates Foundation commits $6.5 million for breath-based diagnostics
2025: Clinical trials underway for a screening test for the early-stage detection of lung cancer, the most common cancer killer in the world responsible for 1.8 million deaths each year
2025: Commercialization of the OMED Health® Breath Analyzer, a hand-held, low-cost medical device for the diagnosis and monitoring of digestive diseases that affect 1 billion people globally.
2025: Further development and launch of the LIBRA® test for the primary care and at-home diagnosis of chronic liver diseases, which account for over 2 million deaths worldwide annually
2025: Owlstone Medical Wins up to $49.1 Million Award from ARPA-H to Develop At-home Multi-Cancer-Early Detection Tests
Jumps
Finance & Acquisition: Owlstone Medical
Key People: Owlstone Medical